The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen
Introduction: The purpose of the present study was to investigate the relationship of expression of hypoxia inducible factor (HIF)-1α-modifying enzymes prolyl hydroxylase (PHD)1, PHD2 and PHD3 to response of tumours and survival in breast cancer patients enrolled in a phase II trial of neoadjuvant a...
Main Authors: | Fox, S, Generali, D, Berruti, A, Brizzi, M, Campo, L, Bonardi, S, Bersiga, A, Allevi, G, Milani, M, Aguggini, S, Mele, T, Dogliotti, L, Bottini, A, Harris, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
by: Fox, S, et al.
Published: (2011) -
Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients
by: Mele, T, et al.
Published: (2010) -
Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.
by: Mele, T, et al.
Published: (2010) -
Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer.
by: Generali, D, et al.
Published: (2007) -
Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer
by: Generali, D, et al.
Published: (2007)